Results of the LEVEL Study

Show Description +

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Results of the LEVEL Study

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Please log in to leave a comment.

More in Retina

Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab

Ben Young, MD; Pheobe Mellen, MD; and Jordan Deaner, MD

Neovascularization in Myopic Eyes

Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI

The Latest Therapies for DR

Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth